Detalhe da pesquisa
1.
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia.
Br J Cancer
; 123(8): 1280-1288, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32684627
2.
Downregulation of PPARα during Experimental Left Ventricular Hypertrophy Is Critically Dependent on Nox2 NADPH Oxidase Signalling.
Int J Mol Sci
; 21(12)2020 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32575797
3.
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
J Pathol
; 245(1): 19-28, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29412457
4.
Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.
Mod Pathol
; 30(9): 1287-1298, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28621318
5.
Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer.
NAR Genom Bioinform
; 3(2): lqab016, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33928242
6.
ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA.
Cancer Res
; 79(8): 2072-2075, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760519
7.
Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer.
Oncotarget
; 9(17): 13834-13847, 2018 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568398
8.
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification.
Nat Commun
; 8: 15657, 2017 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28561046
9.
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility.
Oncotarget
; 6(25): 20863-74, 2015 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26315110